Dec 19, 2023 / 01:30PM GMT
Operator
Good morning, ladies and gentlemen, and welcome to the TFF Pharmaceuticals' TFF. four E. and TFFTAC. program update conference call. As a reminder, this conference is being recorded.
I will now turn the call over to your host, Corey Davis of LifeSci Advisors.
Thank you.
You may begin.
Corey Davis LifeSci Advisors - LLC - IR
Thank you, operator, and hello, everyone, and welcome to TFF Pharmaceuticals, TFF, Maury and TFFTAC. program update conference call.
With me on the line this morning is Dr. Harlan Wiseman, Chief Executive Officer of TFF Pharmaceuticals. Factors dominate Mi-Tech Chief Medical Officer, and Kirk Coleman, Chief Financial Officer.
Before we get started, I'd like to remind everyone that this call will contain forward-looking statements, including without limitation, statements about, including the advancement of TFFORENTFF. tack into registration, enabling clinical trials and the benefits of the Company's TFF platform. These forward-looking statements are subject to known and unknown risks and
TFF Pharmaceuticals Inc to Host Conference Call Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers